Skip to main content

The biomarker niche for fibroblast growth factor 23 testing in CKD.

Publication ,  Journal Article
Wolf, M
Published in: J Am Soc Nephrol
January 2015

Duke Scholars

Published In

J Am Soc Nephrol

DOI

EISSN

1533-3450

Publication Date

January 2015

Volume

26

Issue

1

Start / End Page

7 / 9

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Male
  • Kidney Diseases
  • Humans
  • Gene Expression Regulation
  • Fibroblast Growth Factors
  • Fibroblast Growth Factor-23
  • Female
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wolf, M. (2015). The biomarker niche for fibroblast growth factor 23 testing in CKD. J Am Soc Nephrol, 26(1), 7–9. https://doi.org/10.1681/ASN.2014060621
Wolf, Myles. “The biomarker niche for fibroblast growth factor 23 testing in CKD.J Am Soc Nephrol 26, no. 1 (January 2015): 7–9. https://doi.org/10.1681/ASN.2014060621.
Wolf M. The biomarker niche for fibroblast growth factor 23 testing in CKD. J Am Soc Nephrol. 2015 Jan;26(1):7–9.
Wolf, Myles. “The biomarker niche for fibroblast growth factor 23 testing in CKD.J Am Soc Nephrol, vol. 26, no. 1, Jan. 2015, pp. 7–9. Pubmed, doi:10.1681/ASN.2014060621.
Wolf M. The biomarker niche for fibroblast growth factor 23 testing in CKD. J Am Soc Nephrol. 2015 Jan;26(1):7–9.

Published In

J Am Soc Nephrol

DOI

EISSN

1533-3450

Publication Date

January 2015

Volume

26

Issue

1

Start / End Page

7 / 9

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Male
  • Kidney Diseases
  • Humans
  • Gene Expression Regulation
  • Fibroblast Growth Factors
  • Fibroblast Growth Factor-23
  • Female
  • 3202 Clinical sciences
  • 1103 Clinical Sciences